Crossmark

Benzimidazole-1,2,3-triazole-piperazine hybrids: design, synthesis, antidiabetic evaluation and molecular modelling studies

Published Online: 2022-12-19

Published Print: 2023-03

Authors

Deswal, Laxmi

Verma, Vikas

Kirar, Jagat Singh

Kumar, Devinder

Deswal, Yogesh

Kumar, Ashwani

Bhatia, Meenakshi
License Information

Text and Data Mining valid from 2022-12-19

Version of Record valid from 2022-12-19
More Information

Article History

Received: 22 August 2022

Accepted: 5 December 2022

First Online: 19 December 2022

Declarations

:

: The authors declare that there are no conflicts of interests.

: Not applicable.

Document is current